KF
ABBV icon

Krilogy Financial’s AbbVie ABBV Stock Holding History

Krilogy Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3M Sell
15,789
-155
-1% -$34.4K 0.11% 158
2025
Q4 		$3.52M Sell
15,944
-775
-5% -$177K 0.12% 143
2025
Q3 		$3.62M Buy
16,719
+4,919
+42% +$1M 0.14% 122
2025
Q2 		$2.19M Buy
11,800
+1,178
+11% +$219K 0.13% 131
2025
Q1 		$2.23M Sell
10,622
-710
-6% -$138K 0.14% 119
2024
Q4 		$2.01M Buy
11,332
+225
+2% +$41.4K 0.13% 124
2024
Q3 		$2.19M Sell
11,107
-54
-0.5% -$10.1K 0.15% 122
2024
Q2 		$1.91M Sell
11,161
-111
-1% -$18.4K 0.14% 122
2024
Q1 		$2.05M Buy
11,272
+371
+3% +$63.9K 0.16% 123
2023
Q4 		$1.69M Buy
+10,901
New +$1.59M 0.14% 120
2023
Q2 		– Sell
-10,038
Closed -$1.6M – 206
2023
Q1 		$1.6M Sell
10,038
-5,357
-35% -$819K 0.13% 133
2022
Q4 		$2.49M Buy
15,395
+7,164
+87% +$1.1M 0.24% 72
2022
Q3 		$1.1M Buy
8,231
+374
+5% +$53.7K 0.13% 105
2022
Q2 		$1.2M Buy
7,857
+234
+3% +$35.8K 0.14% 96
2022
Q1 		$1.24M Buy
7,623
+2,674
+54% +$388K 0.13% 115
2021
Q4 		$670K Buy
4,949
+142
+3% +$16.8K 0.07% 169
2021
Q3 		$519K Buy
4,807
+255
+6% +$29.1K 0.05% 187
2021
Q2 		$513K Sell
4,552
-426
-9% -$48K 0.05% 178
2021
Q1 		$539K Buy
4,978
+302
+6% +$32.3K 0.06% 169
2020
Q4 		$501K Sell
4,676
-167
-3% -$16K 0.06% 178
2020
Q3 		$424K Buy
4,843
+922
+24% +$86.8K 0.06% 176
2020
Q2 		$385K Buy
3,921
+423
+12% +$37.2K 0.06% 167
2020
Q1 		$267K Sell
3,498
-25
-0.7% -$2.13K 0.05% 160
2019
Q4 		$312K Buy
+3,523
New +$292K 0.05% 157
2019
Q3 		– Sell
-3,596
Closed -$262K – 188
2019
Q2 		$262K Buy
3,596
+309
+9% +$24.3K 0.05% 149
2019
Q1 		$265K Buy
3,287
+173
+6% +$14.2K 0.06% 148
2018
Q4 		$287K Sell
3,114
-901
-22% -$79.2K 0.08% 100
2018
Q3 		$380K Sell
4,015
-62
-2% -$5.88K 0.09% 98
2018
Q2 		$378K Buy
4,077
+1,062
+35% +$104K 0.1% 93
2018
Q1 		$285K Sell
3,015
-208
-6% -$22.8K 0.07% 128
2017
Q4 		$312K Sell
3,223
-183
-5% -$17.2K 0.08% 119
2017
Q3 		$303K Buy
3,406
+339
+11% +$25.8K 0.08% 114
2017
Q2 		$222K Sell
3,067
-1,263
-29% -$84.9K 0.06% 131
2017
Q1 		$271K Hold
4,330
– – 0.08% 101
2016
Q4 		$271K Buy
4,330
+223
+5% +$13.6K 0.08% 101
2016
Q3 		$259K Buy
4,107
+200
+5% +$12.9K 0.08% 102
2016
Q2 		$242K Sell
3,907
-228
-6% -$13.9K 0.08% 106
2016
Q1 		$236K Buy
4,135
+2,311
+127% +$129K 0.1% 92
2015
Q4 		$108K Buy
1,824
+500
+38% +$28.8K 0.1% 86
2015
Q3 		$72K Buy
+1,324
New +$86.2K 0.03% 162

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Krilogy Financial's ABBV Position: Q1 2026 in Review

Krilogy Financial reduced its AbbVie (ABBV) stake by 0.97% in Q1 2026, selling an estimated $34.4K and leaving 15,789 shares worth $3.3M. The position accounts for 0.11% of the portfolio, ranked #158.

Krilogy Financial first reported a position in ABBV in Q3 2015 and has held it in 40 quarters since. The position peaked at $3.62M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Krilogy Financial held 15,789 shares of AbbVie worth $3.3M as of Q1 2026.
  • Krilogy Financial sold 155 AbbVie shares in Q1 2026, an estimated $34.4K.
  • AbbVie made up 0.11% of Krilogy Financial's portfolio in Q1 2026, its #158 holding.
  • Krilogy Financial first reported a position in AbbVie in Q3 2015 and has held it in 40 quarters since.
  • Krilogy Financial's AbbVie position peaked at $3.62M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.